- Home
- ADIL
as 11-15-2024 4:00pm EST
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.
| Founded: | 2010 | Country: | United States |
| Employees: | N/A | City: | CHARLOTTESVILLE |
| Market Cap: | 6.5M | IPO Year: | 2018 |
| Target Price: | $8.00 | AVG Volume (30 days): | 222.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.41 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.77 - $4.17 | Next Earning Date: | 11-13-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Adial Pharmaceuticals Inc News
ADIL Breaking Stock News: Dive into ADIL Ticker-Specific Updates for Smart Investing
GlobeNewswire
4 days ago
Adial Pharmaceuticals Announces Positive Topline Results from the AD04-103 Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder
Benzinga
4 days ago
EXCLUSIVE: Adial Pharmaceuticals Reveals Topline Results From Pharmacokinetics Study Of AD04 For Alcohol Use Disorder
GlobeNewswire
5 days ago
Adial Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
13 days ago
Adial Pharmaceuticals Appoints Vinay Shah as Chief Financial Officer
GlobeNewswire
a month ago
Adial Pharmaceuticals to Present at the 2024 ThinkEquity Conference
MT Newswires
a month ago
Adial Pharmaceuticals Gets US Patent Allowance for Expanded Genotypes in Addiction Treatment
GlobeNewswire
a month ago
Adial Pharmaceuticals Receives Notice of Allowance for U.S. Patent Covering Expanded Genotype Combinations Identified Using the Company’s Genetic Diagnostic for Addiction Treatment
Benzinga
a month ago
EXCLUSIVE: Adial Pharmaceuticals Secures Additional US Patent Expanding Intellectual Property Protection Around Its Alcohol Use Disorder Candidate
Compare ADIL vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ADIL Adial Pharmaceuticals Inc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.